Search Site

MS Research

For more information about the following studies, please contact Gaby Tosto, BS at 212-342-4649.

Currently Recruiting

  • A Randomized Controlled Trial of Aspirin in Relapsing-Remitting Multiple Sclerosis (RRMS)

  • Educational Outcomes of Cognition in Pediatric Multiple Sclerosis

  • Reserve Against Primary-Progressive Multiple Sclerosis (PPMS) Disability

  • Resting State Functional Connectivity as a Predictor of Memory Decline in Multiple Sclerosis (Condition: Multiple Sclerosis)

  • Development of a test for autoantibodies in Susac Syndrome (Condition: Susac Syndrome)

  • A Randomized Controlled Trial of Vitamin D Supplementation in Multiple Sclerosis (Condition: Multiple Sclerosis)

Active But Not Currently Recruiting

Closed Studies

  • RESPOND: An Observational Study of Tecfidera in relapsing-remitting multiple sclerosis (RRMS).
     
  • A Study Comparing Copaxone and Estriol vs. Copaxone Alone in People With Relapsing-Remitting Multiple Sclerosis (Condition: Multiple Sclerosis)
     
  • Effectiveness and Safety of Fingolimod (FTY720) in Patients With Relapsing-Remitting Multiple Sclerosis (Condition: Multiple Sclerosis)
     
  • A Study Comparing the Combination of Avonex and Copaxone vs. Either Medication Alone in People with Relapsing-Remitting MS (Condition: Multiple Sclerosis)
     
  • A Study of the Effectiveness and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis (Condition: Multiple Sclerosis)
     
  • A Study to Evaluate the Safety and Effectiveness of MBP8298 in People with Secondary Progressive MS (Condition: Multiple Sclerosis)
     
  • Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR (Condition: Multiple Sclerosis)
     
  • Safety and Tolerability of Rituximab in Neuromyelitis Optica (Condition: Neuromyelitis Optica)